SCHEMBL20094597

SCHEMBL20094597

CCCc1c(CC)cccc1NN

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ GAA P10253 2/20 0.45
▸ DHFR P00374 1/20 0.42
▸ GRIN2D O15399 1/20 0.38
▸ GRIN3B O60391 1/20 0.38
▸ GRIN1 Q05586 1/20 0.38
▸ GRIN2A Q12879 1/20 0.38
▸ GRIN2B Q13224 1/20 0.38
▸ GRIN2C Q14957 1/20 0.38
▸ GRIN3A Q8TCU5 1/20 0.38
▸ SIGMAR1 Q99720 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ GABRA1 P14867 2/20 0.38
▸ GABRB2 P47870 2/20 0.38
▸ TAS1R3 Q7RTX0 1/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ CLCN2 P51788 1/20 0.36
▸ HDAC3 O15379 1/20 0.35
▸ HDAC4 P56524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28200857 0.90 MAPT (0.49) MAPTALDH1A1GAADHFRGRIN2D
Bromide SCHEMBL20984551 0.89 MAPT (0.47) MAPTALDH1A1GAADHFRGRIN2D
Hydrochloric Acid SCHEMBL11136234 0.89 ALDH1A1 (0.47) MAPTALDH1A1GAADHFRGRIN2D
Sulfuric Acid SCHEMBL20985018 0.82 ALDH1A1 (0.46) MAPTALDH1A1GAADHFRGRIN2D
Oxalic Acid SCHEMBL20984062 0.82 MAPT (0.46) MAPTALDH1A1GAADHFRGRIN2D
Phosphoric Acid SCHEMBL20984725 0.82 MAPT (0.46) MAPTALDH1A1GAADHFRGRIN2D
SCHEMBL28033756 0.80 POLB (0.37) MAPTALDH1A1GAADHFRPOLB
Nitric Acid SCHEMBL20984767 0.80 MAPT (0.44) MAPTALDH1A1GAADHFRGRIN2D
SCHEMBL597268 0.80 GABRA1 (0.50) ALDH1A1GAAGABRA1GABRB2KCNH2
SCHEMBL7438728 0.76 ALDH1A1 (0.46) MAPTALDH1A1GAAGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180111939-A1 7-(MORPHOLIN-4-YL)PYRAZOLE[1,5-A]PYRIMIDINE DERIVATIVES WHICH ARE USEFUL FOR THE TREATMENT OF IMMUNE OR INFALMMATORY DISEASES OR CANCER CELON PHARMA S.A. (PL) 2018-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180111939-A1 7-(MORPHOLIN-4-YL)PYRAZOLE[1,5-A]PYRIMIDINE DERIVATIVES WHICH ARE USEFUL FOR THE TREATMENT OF IMMUNE OR INFALMMATORY DISEASES OR CANCER AFF2, INF2, AFF1 MAPT 4407/4885ALDH1A1 1194/4885GAA 3735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback